{"id":"W4412507859","doi":"10.1093/noajnl/vdaf160","title":"First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology Advances","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; F. Hoffmann-La Roche","keywords":"Bispecific antibody; Glioblastoma; Antibody; CD3; Cancer research; Medicine; Oncology; Internal medicine; Immunology; Monoclonal antibody; Immune system; CD8","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001680051,0.001220109,0.00168964,0.0004163293,0.0004037684,0.0008390261,0.0008120849,0.0008774879,0.001776441],"category_scores_gemma":[0.000723907,0.0004786131,0.0009771582,0.0003536644,0.0009419391,0.0005473595,0.0002968719,0.00294303,0.0005462877],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001009882,"about_ca_system_score_gemma":0.001613898,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001648869,"about_ca_topic_score_gemma":0.00330898,"domain_scores_codex":[0.9994805,0.0002451118,0.00002551794,0.00006516781,0.00005802328,0.0001256306],"domain_scores_gemma":[0.9992744,0.000101325,0.0001444956,0.00008520234,0.00008795349,0.0003066721],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2572401,0.1945266,0.02082595,0.002177524,0.003060886,0.001442713,0.001111925,0.004800823,0.2320181,0.0004165766,0.005031819,0.2773471],"study_design_scores_gemma":[0.061249,0.8968,0.01322286,0.00005012011,0.0006084224,0.0008229855,0.00007914887,0.0008899426,0.0219669,0.00008416286,0.004195923,0.00003058313],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993885,0.002484213,0.0009418181,0.0001828808,0.00008267441,0.001332221,0.0003068957,0.00006384613,0.0007204754],"genre_scores_gemma":[0.9937199,0.00208105,0.001018278,0.0003810745,0.0001250827,0.0007507349,0.0007484173,0.00002710856,0.001148263],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001776441,"threshold_uncertainty_score":0.008885026,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02170407105458333,"score_gpt":0.3771721298724504,"score_spread":0.355468058817867,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}